C1514474||Prognostic factors
C0347016||spinal metastasis
C1955832||systematic review
C0920317||meta-analysis
C0347016||spinal metastasis
C0012634||disease
C0011109||decision-making
C1955832||systematic reviews
C0920317||meta-analysis
C1514474||prognostic factors
C0347016||spinal metastases
C0008972||study
C1514474||prognostic factors
C0347016||metastatic spine disease
C0282441||literature review
C0920317||meta-analysis
C1514474||prognostic factors
C0347016||spinal metastatic disease
C1518527||observational studies
C0920317||Meta-analysis
C1514474||prognostic factors
C0034036||publications
C1138432||PubMed
C0282574||Embase
C0347016||spinal metastases
C0347016||vertebral metastases
C0347016||spinal metastasis
C0347016||vertebral metastases
C1514474||prognostic factors
C1514474||prognostic factors
C1882950||reviewers
C0282574||Newcastle-Ottawa Scale
C0034036||publication
C0237913||funnel plot
C0237913||Begg test
C0237913||Egger test
C1514474||prognostic factors
C0034036||publications
C0920317||Meta-analysis
C0242481||I(2) method
C0600678||abstracts
C1138432||PubMed
C0282574||Embase
C0242356||database
C0034036||publications
C0034036||publications
C1882950||reviewers
C0920317||meta-analysis
C1514474||prognostic factors
C0150312||presence
C0521654||neurologic deficit
C1274039||surgery
C0560046||non-ambulatory
C0085203||radiotherapy
C0085203||radiotherapy
C0560046||non-ambulatory
C1274039||surgery
C0150312||presence
C0153690||bone metastases
C0150312||presence
C0153690||bone metastases
C1515974||sites
C0150312||presence
C1515974||sites
C0243107||development
C0521654||motor deficit
C0085203||radiotherapy
C0243107||development
C0521654||motor deficit
C0085203||radiotherapy
C0920688||cancer diagnosis
C0085203||radiotherapy
C0282574||Karnofsky Performance Score
C0282574||Karnofsky Performance Score
C0282574||Karnofsky Performance Score
C0282574||Karnofsky Performance Score
C1512162||Eastern Cooperative Oncology Group
C1512162||Eastern Cooperative Oncology Group
C0441800||grade 3-4
C0150312||presence
C0442045||visceral
C0027627||metastases
C0018270||growth
C0027651||tumor
C0282574||Tomita score (TS) classification
C0018270||growth
C0027651||tumor
C0282574||TS classification
C1514474||prognostic factors
C0008972||study
C0006826||cancer
C1514474||prognostic factors
C0027651||tumor
C0282574||prognostic scoring system
C0347016||metastatic spine disease